By Dr Jennifer Claire Massey

Journal articles

Kalincik T; Sharmin S; Roos I; Massey J; Sutton I; Withers B; Freedman MS; Atkins H; Krasulova E; Kubala Havrdova E; Trneny M; Kozak T; Burman J; MacDonell R; Torkildsen Ø; Bø L; Lehmann AK; Sharrack B; Snowden J, 2024, 'Effectiveness of autologous haematopoietic stem cell transplantation versus natalizumab in progressive multiple sclerosis', Journal of Neurology, Neurosurgery and Psychiatry, 95, pp. 775 - 783, http://dx.doi.org/10.1136/jnnp-2023-332790

Brown JD; Muston BT; Massey J, 2024, 'Switching from natalizumab to an anti-CD20 monoclonal antibody in relapsing remitting multiple sclerosis: A systematic review', Multiple Sclerosis and Related Disorders, 86, http://dx.doi.org/10.1016/j.msard.2024.105605

Pang V; Seery N; Wesselingh R; Yeh W; Zhong M; Tan T; Dwyer C; Nesbitt C; Rath L; Perera D; Bridge F; Skibina O; Bosco JJ; Jokubaitis V; Marriott M; Butkueven H; Van Der Walt A; Massey J; Sutton I; Monif M, 2024, 'Neutropaenia complications from Ocrelizumab and Rituximab treatment', Multiple Sclerosis and Related Disorders, 81, http://dx.doi.org/10.1016/j.msard.2023.105147

Massey J; Visweswaran M; Khoo M; Hendrawan K; Sutton I; Withers B; Ma D; Moore J, 2023, 'Detailed immunophenotyping of the hematopoietic graft from patients with multiple sclerosis undergoing autologous hematopoietic stem cell transplant', Cytotherapy, 25, pp. 1271 - 1276, http://dx.doi.org/10.1016/j.jcyt.2023.08.010

Sharmin S; Roos I; Simpson-Yap S; Malpas C; Sánchez MM; Ozakbas S; Horakova D; Havrdova EK; Patti F; Alroughani R; Izquierdo G; Eichau S; Boz C; Zakaria M; Onofrj M; Lugaresi A; Weinstock-Guttman B; Prat A; Girard M; Duquette P; Terzi M; Amato MP; Karabudak R; Grand’Maison F; Khoury SJ; Grammond P; Lechner-Scott J; Buzzard K; Skibina O; van der Walt A; Butzkueven H; Turkoglu R; Altintas A; Maimone D; Kermode A; Shalaby N; Pesch VV; Butler E; Sidhom Y; Gouider R; Mrabet S; Gerlach O; Soysal A; Barnett M; Kuhle J; Hughes S; Sa MJ; Hodgkinson S; Oreja-Guevara C; Ampapa R; Petersen T; Ramo-Tello C; Spitaleri D; McCombe P; Taylor B; Prevost J; Foschi M; Slee M; McGuigan C; Laureys G; Hijfte LV; de Gans K; Solaro C; Oh J; Macdonell R; Aguera-Morales E; Singhal B; Gray O; Garber J; Wijmeersch BV; Simu M; Castillo-Triviño T; Sanchez-Menoyo JL; Khurana D; Al-Asmi A; Al-Harbi T; Deri N; Fragoso Y; Lalive PH; Sinnige LGF; Shaw C; Shuey N; Csepany T; Sempere AP; Moore F; Decoo D; Willekens B; Gobbi C; Massey J; Hardy T; Parratt J; Kalincik T, 2023, 'The risk of secondary progressive multiple sclerosis is geographically determined but modifiable', Brain, 146, pp. 4633 - 4644, http://dx.doi.org/10.1093/brain/awad218

Massey J; Artuz C; Dyer Z; Jackson K; Khoo M; Visweswaran M; Withers B; Moore J; Ma D; Sutton I, 2023, 'Diversification and expansion of the EBV-reactive cytotoxic T lymphocyte repertoire following autologous haematopoietic stem cell transplant for multiple sclerosis', Clinical Immunology, 254, http://dx.doi.org/10.1016/j.clim.2023.109709

Kalincik T; Sharmin S; Roos I; Freedman MS; Atkins H; Burman J; Massey J; Sutton I; Withers B; MacDonell R; Grigg A; Torkildsen Ø; Bo L; Lehmann AK; Havrdova EK; Krasulova E; Trněný M; Kozak T; Van Der Walt A; Butzkueven H; McCombe P; Skibina O; Lechner-Scott J; Willekens B; Cartechini E; Ozakbas S; Alroughani R; Kuhle J; Patti F; Duquette P; Lugaresi A; Khoury SJ; Slee M; Turkoglu R; Hodgkinson S; John N; Maimone D; Sa MJ; Van Pesch V; Gerlach O; Laureys G; Van Hijfte L; Karabudak R; Spitaleri D; Csepany T; Gouider R; Castillo-Triviño T; Taylor B; Sharrack B; Snowden JA; Mrabet S; Garber J; Sanchez-Menoyo JL; Aguera-Morales E; Blanco Y; Al-Asmi A; Weinstock-Guttman B; Fragoso Y; De Gans K; Kermode A, 2023, 'Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis', JAMA Neurology, 80, pp. 702 - 713, http://dx.doi.org/10.1001/jamaneurol.2023.1184

Dyer Z; Tscharke D; Sutton I; Massey J, 2023, 'From bedside to bench: how existing therapies inform the relationship between Epstein–Barr virus and multiple sclerosis', Clinical and Translational Immunology, 12, http://dx.doi.org/10.1002/cti2.1437

Massey J; Jackson K; Singh M; Hughes B; Withers B; Ford C; Khoo M; Hendrawan K; Zaunders J; Charmeteau-De Muylder B; Cheynier R; Luciani F; Ma D; Moore J; Sutton I, 2022, 'Haematopoietic Stem Cell Transplantation Results in Extensive Remodelling of the Clonal T Cell Repertoire in Multiple Sclerosis', Frontiers in Immunology, 13, http://dx.doi.org/10.3389/fimmu.2022.798300

Visweswaran M; Hendrawan K; Massey JC; Khoo ML; Ford CD; Zaunders JJ; Withers B; Sutton IJ; Ma DDF; Moore JJ, 2022, 'Sustained immunotolerance in multiple sclerosis after stem cell transplant', Annals of Clinical and Translational Neurology, 9, pp. 206 - 220, http://dx.doi.org/10.1002/acn3.51510

Hendrawan K; Khoo MLM; Visweswaran M; Massey JC; Withers B; Sutton I; Ma DDF; Moore JJ, 2022, 'Long-Term Suppression of Circulating Proinflammatory Cytokines in Multiple Sclerosis Patients Following Autologous Haematopoietic Stem Cell Transplantation', Frontiers in Immunology, 12, http://dx.doi.org/10.3389/fimmu.2021.782935

Chatterton S; Withers B; Sutton IJ; Milliken ST; Ma DDF; Moore JJ; Massey JC, 2021, 'Pregnancy post autologous stem cell transplant with BEAM conditioning for multiple sclerosis', Multiple Sclerosis Journal, 27, pp. 2112 - 2115, http://dx.doi.org/10.1177/13524585211005660

Hankey GJ; Hackett ML; Almeida OP; Flicker L; Mead GE; Dennis MS; Etherton-Beer C; Ford AH; Billot L; Jan S; Lung T; Lundström E; Sunnerhagen KS; Anderson CS; Thang-Nguyen H; Gommans J; Yi Q; Calic Z; ORourke F; Katrak P; Massey J; Carcel C; Delcourt C; Zagami A, 2021, 'Twelve-Month Outcomes of the affinity trial of fluoxetine for functional recovery after acute stroke: Affinity trial steering committee on behalf of the AFFINITY Trial Collaboration', Stroke, 52, pp. 2502 - 2509, http://dx.doi.org/10.1161/STROKEAHA.120.033070

Hankey GJ; Hackett ML; Almeida OP; Flicker L; Mead GE; Dennis MS; Etherton-Beer C; Ford AH; Billot L; Jan S; Lung T; Murray V; Lundström E; Anderson CS; Herbert R; Carter G; Donnan GA; Nguyen HT; Gommans J; Yi Q; Li Q; Bompoint S; Barrett S; Claxton A; O'Dea J; Tang M; Williams C; Peterson S; Drummond C; Hong UH; Le LTM; Ngo TTB; Mai YB; Han HT; Truong NQ; Nguyen HT; Ngo HT; Nguyen TB; Ha OTK; Nguyen TLH; Lindley RI; New P; Lee A; Tran TT; Le LTTM; Kieu TLV; Nguyen SV; Nguyen TAD; Dang TN; Phan HTT; Vo LTN; Nguyen MH; Dang HC; Tran HT; Dam LTC; Ngo TTK; Pham TNT; Pham BN; Dao NTT; Le LTC; Do CM; Huynh HQ; Tran GTK; Le OT; Tran LTK; Duong CD; Kieu DV; Le N; Nguyen HN; Le BV; Nguyen LT; Nguyen LV; Dinh TQ; Vo TV; Bui TN; Hoang UTT; Nguyen HTB; Nguyen HTT; Lam NT; Le KK; Trinh PT; Huynh HQ; Nguyen TTT; Lu HN; Pham TH; Nguyen SH; Le NH; Nguyen GT; Doan BT; Pham SP; Luong DH; Mai HV; Tran TV; Do PT; Le HT; Nguyen CV; Nguyen PD; Mai TD; Dao PV; Markus R; Calic Z; Katrak P; Faux S; Delcourt C; Carcel C; McDougall A; ORourke F; Cordato D; Jude M; Zagami A; Massey J, 2020, 'Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial', The Lancet Neurology, 19, pp. 651 - 660, http://dx.doi.org/10.1016/S1474-4422(20)30207-6

Massey J; Barnett Y; Curnow J; Sutton I, 2019, 'B cell depletion therapy resulting in sustained remission of severe autoimmune complications following Alemtuzumab treatment of Multiple Sclerosis', Multiple Sclerosis and Related Disorders, 35, pp. 100 - 103, http://dx.doi.org/10.1016/j.msard.2019.07.016

Massey Jennifer C ; Moore John J ; Milliken Samuel T ; Ma David D F , 2019, 'Autologous hematopoietic stem cell transplant for autoimmune diseases: evolution,evidence of efficacy, and real-world economics.', Blood Cell Ther, 2, pp. 12 - 21, http://dx.doi.org/10.31547/bct-2018-009

Moore JJ; Massey JC; Ford CD; Khoo ML; Zaunders JJ; Hendrawan K; Barnett Y; Barnett MH; Kyle KA; Zivadinov R; Ma KC; Milliken ST; Sutton IJ; Ma DDF, 2019, 'Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosis', Journal of Neurology, Neurosurgery and Psychiatry, 90, pp. 514 - 521, http://dx.doi.org/10.1136/jnnp-2018-319446

Giarola B; Massey J; Barnett Y; Rodrigues M; Sutton I, 2019, 'Autoimmune encephalitis following alemtuzumab treatment of multiple sclerosis', Multiple Sclerosis and Related Disorders, 28, pp. 31 - 33, http://dx.doi.org/10.1016/j.msard.2018.12.004

Massey J; Walker S; Galloway M; Fernando S; Parratt J; Quigley AM; Kidd DP, 2019, 'Granulomatous CNS inflammation associated with seminoma', Journal of Neurology, 266, pp. 1389 - 1393, http://dx.doi.org/10.1007/S00415-019-09270-8

Massey JC; Sutton IJ; Ma DDF; Moore JJ, 2018, 'Regenerating immunotolerance in multiple sclerosis with autologous hematopoietic stem cell transplant', Frontiers in Immunology, 9, http://dx.doi.org/10.3389/fimmu.2018.00410

Massey J, 2017, 'Posterior reversible encephalopathy syndrome (PRES) with sub-arachnoid haemorrhage after bevacizumab and 5-FU', Journal of Clinical Neuroscience, 40, pp. 57 - 59, http://dx.doi.org/10.1016/j.jocn.2017.01.005

Massey J; Kumar K; Ng K; Yun J; Fernando S, 2017, 'Skeletal myositis as the sole feature of relapsing drug reaction with eosinophilia and systemic symptoms syndrome', Annals of Allergy, Asthma and Immunology, 118, pp. 726 - 728, http://dx.doi.org/10.1016/j.anai.2017.03.007

McCaughan G; Massey J; Sutton I; Curnow J, 2017, 'Acquired haemophilia A complicating alemtuzumab therapy for multiple sclerosis', BMJ Case Reports, 2017, http://dx.doi.org/10.1136/bcr-2017-223016

Massey J, 2017, 'IgG4-related hypertrophic pachymeningitis coexpressing antineutrophil cytoplasmic antibodies', Neurology: Neuroimmunology and NeuroInflammation, 4, http://dx.doi.org/10.1212/NXI.0000000000000341

Yun J; Cai F; Massey J; Brewer J; Kumar K; Fernando SL, 2016, 'SULPHASALAZINE-INDUCED DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS (DRESS) ASSOCIATED WITH NECROTISING EOSINOPHILIC MYOSITIS - A NOVEL FINDING', INTERNAL MEDICINE JOURNAL, 46, pp. 28 - 28, http://dx.doi.org/10.1111/imj.76_13197

Massey J; Buckland ME; Barnett Y; Sutton I, 2016, 'Expanding the range of immunopathology in neuromyelitis optica spectrum disorder', BMJ Case Reports, 2016, http://dx.doi.org/10.1136/bcr-2016-215981

Massey JS; Meares S; Batchelor J; Bryant RA, 2015, 'An exploratory study of the association of acute posttraumatic stress, depression, and pain to cognitive functioning in mild traumatic brain injury', Neuropsychology, 29, pp. 530 - 542, http://dx.doi.org/10.1037/neu0000192

Roxanas MG; Massey JS; Chaganti J, 2014, 'Antisocial behaviour and lying: A neuropsychiatric presentation of agenesis of the corpus callosum', Australasian Psychiatry, 22, pp. 461 - 466, http://dx.doi.org/10.1177/1039856214546535

Sanders DB; Andrews PI; Howard JF; Massey JM, 1997, 'Seronegative myasthenia gravis', Neurology, 48

Back to profile page